US5414077AExpiredUtility

Non-nucleoside linkers for convenient attachment of labels to oligonucleotides using standard synthetic methods

98
Assignee: GILEAD SCIENCESPriority: Feb 20, 1990Filed: May 2, 1994Granted: May 9, 1995
Est. expiryFeb 20, 2010(expired)· nominal 20-yr term from priority
C07C 215/14C07D 219/12A61K 47/50Y02P20/55A61K 47/61C07H 21/00C07C 217/10C07C 225/34C07C 219/06C07C 233/36C07C 233/18C07J 51/00
98
PatentIndex Score
912
Cited by
58
References
9
Claims

Abstract

Pseudonucleosides and pseudonucleotides are useful in the synthesis of oligomers which contain these components as a means to derivatize the resulting oligonucleotide to useful substituents such as chelators, intercalators, or lipophilic compounds. In general, these pseudonucleotide components are of the formula: ##STR1## wherein each Y is independently O or S; each X is independently H, PO 3 -2 , an activated nucleotide synthesis coupling moiety, a protecting group, a nucleoside, a nucleotide or a nucleotide sequence, or comprises a solid support; F is a functional group capable of linking an additional moiety or said group already reacted to effect the binding of said additional moiety; □ is an organic backbone which does not contain additional F or Y-X substituents and which is either achiral even when the Y-X substituents are different, or is a single enantiomer of a chiral compound; with the proviso that at least one X is a nucleoside, nucleotide, nucleotide sequence, an activated nucleotide synthesis coupling moiety, or comprises a solid support, or F represents said functional group already reacted with an additional group. Oligonucleotides having the pseudonucleoside at the 3' terminus are particularly stable in vivo.

Claims

exact text as granted — not AI-modified
We claim: 
     
       1. A compound of the formula ##STR7## wherein n is an integer of 1 to 10; each Y is independently O or S; and wherein one X is selected from the group consisting of a nucleoside, a nucleotide, an oligonucleotide, an activated nucleotide synthesis coupling moiety and a solid support linked to Y and the other X is selected from the group consisting of H PO 3   2- , a protecting group, a nucleoside, a nucleotide, and an oligonucleotide; and   wherein F is a functional group capable of linking an additional moiety or a functional group and said additional moiety linked thereto, wherein said additional moiety is selected from the group consisting of a reporter group, an oligonucleotide cleavage entity, an oligonucleotide binding agent, a membrane penetration enhancer, an oligonucleotide crosslinking agent and a protecting group.   
     
     
       2. The compound of claim 1 wherein one X is a protecting group and the other X is an activated nucleotide synthesis coupling moiety. 
     
     
       3. The compound of claim 1 wherein one X is a protecting group or H and the other X is a solid support linked to Y. 
     
     
       4. The compound of claim 1 wherein F is a protecting group linked to N. 
     
     
       5. The compound of claim 4 wherein n is 2-6. 
     
     
       6. The compound of claim 1 wherein F is -(CH 2 ) n'  Y'Pr wherein n' is 1-5, Y' is NH, O or S and Pr is a protecting group. 
     
     
       7. The compound of claim 1 wherein n is 2-6. 
     
     
       8. The compound of claim 7 wherein both Y are 0. 
     
     
       9. The compound of claim 1 wherein F is selected from the group consisting of ethyl, cholesteryl, acridine, anthraquinone, and rhodamine linked to N.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.